B. Purpose of the requirement, Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol Version 6, 08 Jul 2020, MHRA, Medicines & Healthcare products Regulatory Agency
The new requirement was implemented in UK legislation in order to:
1. Enhance the safety of trial subjects/patients by seeking to ensure that the licensing authority is promptly informed of such serious breaches, in order to take appropriate action in response to the breach and/or,
2. To take the information regarding serious breaches into account when assessing future applications for clinical trial authorisation, and applications for marketing authorisation, which include data from trials affected by serious breaches.
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demandACROSS Global Training AcademyOnline
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Prossimi studi clinici
-
King Chulalongkorn Memorial HospitalHealth Systems Research Institute,ThailandReclutamentoDemenza | Malattia di Alzheimer | Declino cognitivoTailandia
-
Hospital Universitari de BellvitgeHospital Universitario Ramon y Cajal; Complejo Hospitalario de Navarra; University... e altri collaboratoriNon ancora reclutamentoNeoplasie delle vie biliari | Cancro al pancreas resecabile | Ostruzione biliare malignaSpagna
-
University Hospitals of North Midlands NHS TrustNon ancora reclutamento
-
Second Affiliated Hospital, School of Medicine,...Non ancora reclutamentoSclerosi sistemica cutanea diffusaCina
-
AstraZenecaReclutamento
-
VA Eastern Colorado Health Care SystemReclutamentoTerapie cognitivo comportamentali computerizzate per la prevenzione del suicidio e della depressioneDepressione | SuicidioStati Uniti
-
Convalife (Shanghai) Co., Ltd.Non ancora reclutamentoGiunzione esofagea/esofagogastrica/adenocarcinoma gastrico avanzato Her2-positivo con metastasi cerebrali
-
Stanford UniversityNon ancora reclutamento
-
Sunway UniversityReclutamentoInvecchiamento | Anziano | Declino cognitivo | Studio di intervento | Declino fisicoMalaysia
-
The First Affiliated Hospital with Nanjing Medical...Zhejiang Cancer HospitalReclutamento
-
University GhentNon ancora reclutamentoComportamento di ricerca di aiuto | Prevenzione del suicidio | UominiBelgio
-
Beijing Chest Hospital, Capital Medical UniversityNon ancora reclutamentoCancro polmonare a piccole cellule in stadio limitato